医学
肾脏疾病
内科学
糖尿病
2型糖尿病
梅德林
重症监护医学
内分泌学
政治学
法学
作者
George L. Bakris,Luís M. Ruilope,Stefan D. Anker,Gerasimos Filippatos,Bertram Pitt,Peter Rossing,Linda P. Fried,Prabir Roy‐Chaudhury,Pantelis Sarafidis,Christiane Ahlers,Meike Brinker,Amer Joseph,Robert Lawatscheck,Rajiv Agarwal
标识
DOI:10.1016/j.kint.2022.08.040
摘要
, respectively). Thus, finerenone improved kidney outcomes, reduced the hazard of ESKD, and is well tolerated in patients with chronic kidney disease and type 2 diabetes.
科研通智能强力驱动
Strongly Powered by AbleSci AI